AACR-IASLC Joint Conference on
Molecular Origins of Lung Cancer:
Biology, Therapy, and Personalized Medicine
January 8-11, 2012
San Diego Marriott Marina & Hotel
San Diego, CA
Abstract submission deadline: Monday, October 31
Advance registration deadline: Wednesday, November 23
CONFERENCE CO-CHAIRPERSONS:
David P. Carbone, Vanderbilt-Ingram Cancer Center, Nashville, TN
Roy S. Herbst, Yale University, New Haven, CT
PROGRAM COMMITTEE:
Denise Aberle, UCLA David Geffen School of Medicine, Los Angeles, CA
Bonnie J. Addario, Bonnie J. Addario Lung Cancer Foundation, San Carlos, CA (Advocate)
Christine Berg, NCI-DCP, Bethesda, MD
David R. Gius, Vanderbilt School of Medicine, Nashville, TN
Eric B. Haura, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
Waun Ki Hong, University of Texas MD Anderson Cancer Center, Houston, TX
David M. Jablons, University of California, San Francisco, CA
Jonathan M. Kurie, University of Texas MD Anderson Cancer Center, Houston, TX
Jin Soo Lee, National Cancer Center, Seoul, Korea
Matthew L. Meyerson, Dana-Farber Cancer Institute, Boston, MA
Tetsuya Mitsudomi, Aichi Cancer Center Hospital, Nagoya, Japan
Tony S.K. Mok, Chinese University of Hong Kong, Hong Kong, China
Kim Norris, Lung Cancer Foundation of America, Los Angeles, CA (Advocate)
William Pao, Vanderbilt-Ingram Cancer Center, Nashville, TN
Katerina Politi, Yale University, New Haven, CT
Garth Powis, University of Texas MD Anderson Cancer Center, Houston, TX
Joan H. Schiller, UT Southwestern Medical Center, Dallas, TX
Jean-Charles Soria, Institut Gustave-Roussy, Villejuif, France
Gabriella Sozzi, Fundacion IRCCS Instituto Nazionale dei Tumori, Milan, Italy
Avrum E. Spira, Boston University School of Medicine, Boston, MA
Continuing Medical Education Activity - AMA PRA Category 1 CreditsTM available